Found 53 matching trials
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma PHASE2 This is a multicenter, randomized, double-blind, controlled Phase 2/3 trial...
Show More Status
Active Not Recruiting
Location
Exelixis Clinical Site #2
Learn More & Join Trial
The Effect of Prebiotic Inulin on Patients Affected by R/M HNSCC Treated With Immune Checkpoint Inhibitors NA The PRINCESS study is a hypothesis-generating, interventional, open-label, ...
Show More Location
Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
Learn More & Join Trial
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma PHASE2 Background:
* The National Cancer Institute (NCI) Surgery Branch has devel...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC PHASE2 This study is to determine if Healthy Donor FMT (hdFMT) improves the body's...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial studies how well giving pembrolizumab with s...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) PHASE1 This study consists of several parts: dose escalation, dose expansion, dose...
Show More Location
University of California at San Francisco ( Site 0004)
Learn More & Join Trial
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors PHASE1 The main purpose of this study is to establish the safety and the recommend...
Show More Status
Active Not Recruiting
Location
HonorHealth Research Institute
Learn More & Join Trial
Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer PHASE1 Squamous cell carcinoma of the head and neck, which accounts for 90% of hea...
Show More Location
Medical University of Vienna
Learn More & Join Trial
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) PHASE2 Researchers are looking for new ways to treat metastatic nonsquamous non-sm...
Show More Location
University of Kentucky Chandler Medical Center ( Site 0019)
Learn More & Join Trial
Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC PHASE3 This is an open-label, randomized, prospective, multicenter phase III trial...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial